Xeris Biopharma Holdings, Inc. - Common Stock — Quarterly Balance Sheet (NASDAQ:XERS) | MetaTrader

Open full chart

News

Xeris Biopharma: A Commercial Stage Pharma That May Be A Slow-Burn Buy Opportunity (XERS)

Compared to Estimates, Xeris Biopharma (XERS) Q2 Earnings: A Look at Key Metrics

Zevra Therapeutics (ZVRA) Q2 Earnings and Revenues Surpass Estimates

Xeris Biopharma (XERS) Moves 6.8% Higher: Will This Strength Last?

Xeris Looks Ridiculously Cheap If Growth Forecasts Are Even Halfway Right (NASDAQ:XERS)

Xeris Biopharma (XERS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Xeris Pharmaceuticals at Barclays: Strong Growth Fueled by RECORLEV

Xeris Biopharma Holdings, Inc. (XERS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Xeris Biopharma (XERS) Reports Q4 Earnings: What Key Metrics Have to Say

Xeris Biopharma (XERS) Q4 Earnings and Revenues Surpass Estimates

Xeris Biopharma stock up nearly 3% after Q4 EPS beat, above estimate guidance

Xeris Pharmaceuticals earnings beat by $0.04, revenue topped estimates